Paragonimiasis.
Blair D.
Adv Exp Med Biol. 2019;1154:105-138. doi: 10.1007/978-3-030-18616-6_5.
Paragonimiasis.
Blair D.
Adv Exp Med Biol. 2024;1454:203-238. doi: 10.1007/978-3-031-60121-7_6.
Paragonimiasis.
Chai JY.
Handb Clin Neurol. 2013;114:283-96. doi: 10.1016/B978-0-444-53490-3.00023-6.
Preparation of colloidal gold immunochromatographic strip for detection of Paragonimiasis skrjabini.
Wang Y, Wang L, Zhang J, Wang G, Chen W, Chen L, Zhang X.
PLoS One. 2014 Mar 18;9(3):e92034. doi: 10.1371/journal.pone.0092034. eCollection 2014.
Paragonimus and paragonimiasis in Asia: An update.
Yoshida A, Doanh PN, Maruyama H.
Acta Trop. 2019 Nov;199:105074. doi: 10.1016/j.actatropica.2019.105074. Epub 2019 Jul 8.
Triclabendazole in the treatment of Paragonimiasis skrjabini.
Gao J, Liu Y, Wang X, Hu P.
Chin Med J (Engl). 2003 Nov;116(11):1683-6.
Paragonimus & paragonimiasis in India.
Singh TS, Sugiyama H, Rangsiruji A.
Indian J Med Res. 2012 Aug;136(2):192-204.
Estimation of disability weight for paragonimiasis: a systematic analysis.
Feng Y, Fürst T, Liu L, Yang GJ.
Infect Dis Poverty. 2018 Oct 19;7(1):110. doi: 10.1186/s40249-018-0485-5.
Paragonimus and paragonimiasis in Vietnam: an update.
Doanh PN, Horii Y, Nawa Y.
Korean J Parasitol. 2013 Dec;51(6):621-7. doi: 10.3347/kjp.2013.51.6.621. Epub 2013 Dec 31.
Infection and biogeographical characteristics of Paragonimus westermani and P. skrjabini in humans and animal hosts in China: A systematic review and meta-analysis.
Liu K, Sun YC, Pan RT, Xu AL, Xue H, Tian N, Zheng JX, Shi FY, Lu Y, Li LH.
PLoS Negl Trop Dis. 2024 Aug 5;18(8):e0012366. doi: 10.1371/journal.pntd.0012366. eCollection 2024 Aug.
